jagomart
digital resources
picture1_Excel Sheet Download 11597 | Batch Notification Application Form Revision N 11 | Sample Application


 262x       Filetype XLSX       File size 0.94 MB       Source: www.fda.gov.ph


File: Excel Sheet Download 11597 | Batch Notification Application Form Revision N 11 | Sample Application
sheet 1 as form republic of the philippinesdepartment of healthfood and drug administrationcivic drive filinvest corporate cityalabang city of muntinlupa republic of the philippinesdepartment of healthfood and drug administrationcivic drive ...

icon picture XLSX Filetype Excel XLSX | Posted on 05 Jul 2022 | 3 years ago
Partial file snippet.
Sheet 1: AS Form
Republic of the Philippines
Department of Health
FOOD AND DRUG ADMINISTRATION
Civic Drive, Filinvest Corporate City
Alabang, City of Muntinlupa

Republic of the Philippines
Department of Health
FOOD AND DRUG ADMINISTRATION
Civic Drive, Filinvest Corporate City
Alabang, City of Muntinlupa





ASSESSMENT SLIP
ASSESSMENT SLIP

DTN : Lab No.:
Date: 30 December 1899


DTN : Lab No.:
Date: 30 December 1899






























Company Name: 0


Company Name: 0

Product Information


Product Information

Product Name: List of Generic Names (please use drop down menu) Expiry Date: 0


Product Name: List of Generic Names (please use drop down menu) Expiry Date: 0

Batch/Lot Number:
/
No. of Samples:


Batch/Lot Number:
/
No. of Samples:





























Type of Request:
Type of Request:































Certificate/ Evaluation




Amendment







Certificate/ Evaluation




Amendment


































X Batch Notification




Others




X Batch Notification




Others

































Lot Release Certificate (Vaccine)










Lot Release Certificate (Vaccine)






































LGU Purchases










LGU Purchases






































Purchase










Purchase




































Analysis Requested:
Analysis Requested:































Visual Examination




Aerobic Plate Count







Visual Examination




Aerobic Plate Count



































Dissolution




Coliform/E.Coli (MPN)







Dissolution




Coliform/E.Coli (MPN)



































pH




Yeast and Molds







pH




Yeast and Molds



































Identification Test




Presumptive Test (Salmonella)







Identification Test




Presumptive Test (Salmonella)



































Tablet Hardness




Staphylococcus Aureus Count







Tablet Hardness




Staphylococcus Aureus Count



































Sterility Test




Heavy Metals







Sterility Test




Heavy Metals



































Baterial Endotoxin Test (LAL)




Vitamins







Baterial Endotoxin Test (LAL)




Vitamins



































Assay/Potency (Single Component)




Others:




Assay/Potency (Single Component)




Others:
































Assay/Potency (Multi Component)









Assay/Potency (Multi Component)

















































Assessed by:







Assessed by:



































Payment Details













Payment Details












Amount:




Amount:



OR Number:




OR Number:



Date:




Date:




























































Date Effective: 4-Nov-19 Assessment Slip
Date Effective: 4-Nov-19 Assessment Slip
Form No.: QSP-CSL-PRO-01 Annex 3 Revision No.: 02 Page 1 of 1
Form No.: QSP-CSL-PRO-01 Annex 3 Revision No.: 02 Page 1 of 1


Sheet 2: BN Form




A N T I B I O T I C D R U G P R O D U C T B A T C H N O T I F I C A T I O N





B A T C H N O T I F I C A T I O N N U M B E R












T O B E F I L L E D U P B Y F D A O F F I C I A L


Date:



Assessed and Received by




Date


P A Y M E N T I N F O R M A T I O N

THE DIRECTOR GENERAL
Amount Php


Food and Drug Administration


Civic Drive, Filinvest City, Alabang 1781
OR Number


Muntinlupa City, Philippines




Date


ATTENTION: COMMON SERVICES LABORATORY












Sir/Madam:




In accordance with Administrative Order No. 2008-0033, we wish to apply and notify the FDA of our intention to have our batch of antibiotic product, more particularly described below, exempted from the required batch notification





P R O D U C T P A R T I C U L A R S


Generic Name/s : List of Generic Names (please use drop down menu)


(to be filled up if the generic name is not found in the drop down menu)


Brand Name :



Dosage Strength :



Dosage Form :
Route of Administration :



Batch Number :
Lot Number :



Manufacturing Date :



Expiration Date :



FDA Registration No. :



CPR Validity :



Batch Size :



Theoretical Yield in Number of Units :



Actual Yield/Volume of Importation in Number of Units (as indicated in the commercial invoice) :






Packaging Type :



Presentation or Pack Size :



C O M P A N Y P A R T I C U L A R


Manufacturer's Name
LTO Number


LTO Validity







Trader's Name
LTO Number


LTO Validity







Importer's Name
LTO Number


LTO Validity







Distributor's/Wholesaler's Name
LTO Number


LTO Validity







Repacker's Name
LTO Number


LTO Validity







Others (Packed by; Packed For; Marketed By; Marketed For; Repacked for)
LTO Number


LTO Validity










































NOTE:
Please fill-out the form completely in A4 size paper and write all entries legibly.



































Date Effective:

20 January 2020
Batch Notification Application Form

Form No.:





QWP-A/ANT/W-01 Annex 1
Revision No.: 11
Page 1 of 3











































































DECLARATION


In support of our exemption from batch certification, I, the undersigned, hereby declare under oath that:




























1. I am duly authorized to bind the establishment I represent pursuant to the authority attached to this Notification form (Board Resolution in case of corporation and Special Power of Attorney in all other cases both of which should be duly notarized);




2. In behalf of my company, the antibiotic drug product identified in the notification meets all the legal requirements, and conforms to all existing standards and specification requirement applicable to the above product subject of exemption.




3. I declare that the particulars given in this notification are true and all data and information of relevance in relation to the exemption have been supplied, as well as, the documents attached herein are authentic or true copies.




4. I agree that the acceptance and signing of this Notification shall not constitute as an agreement by FDA in anyway, that the particular batch of the antibiotic drug product produced or imported meets all other pertinent regulatory requirements, such as but not limited to, the product’s conformance to its registered specification or approved labelling.




5. I agree that the grant of exemption shall be automatically revoked by the FDA in the event that there is subsequent findings of misrepresentation in any of the data indicated in the required documents or any of the said documents is subsequently found to be falsified or fraudulently filed; and/or in case the samples belonging to the same batch or batches of antibiotic drug product/s collected through post monitoring surveillance shall be found not to conform to the product’s registered specification or approved labeling.




6. The company I represent shall automatically cease and desist from further distributing the batch or batches of the antibiotic product subject of revocation upon receipt of the notice of revocation and pending any administrative proceeding until further notice of the FDA.




7. I or my company undertake to:






i.
Ensure that the product’s technical and safety information is made readily available to the Food and Administration (FDA) anytime when requested, and to keep records of the distribution of the products for product recall purposes;






ii.
Notify the FDA as soon as possible by telephone, facsimile transmission, email or in writing, and in any case, no later than 7 calendar days after first knowledge of any fatal or life threatening serious adverse event if the cause, whether proximate or otherwise, of such adverse events is the use of the antibiotic product subject of the exemption;






iii.
Report to the FDA of all other serious adverse events that are not fatal or life threatening as soon as possible, and in any case, no later than 15 calendar days after first knowledge, using the Adverse Drug Event Report Form if the cause, whether proximate or otherwise, of such adverse events is the use of the antibiotic product subject of the exemption;






iv.
Keep or hold FDA free and harmless against any and all third party claims arising from the above adverse events or from the exemption of the subject antibiotic product; and






v.
Respond to and cooperate fully with the Food-Drug Regulatory Officers with regard to any subsequent post-marketing activity initiated by the FDA.




8. I understand that our company or establishment cannot place reliance on the acceptance of our antibiotic drug product notification by the FDA in any legal proceeding concerning the above product, in the event that said product has failed to conform to any of the standards or specifications previously declared to the FDA.


































































































































































































































































































































































































Date Effective:

20 January 2020
Batch Notification Application Form

Form No.:





QWP-A/ANT/W-01 Annex 1
Revision No.: 11
Page 2 of 3





































































































COMPANY PHARMACIST





























































Company Name :













Signature :













Printed Name :













Position/Designation :













Email Address :













Contact Number :













Date :
























































ACKNOWLEDGEMENT





























SUBSCRIBED AND SWORN TO BEFORE ME this __________________________________





personally appeared the following:





























Name Residence Certificate Date Issued Place Issued































































Known to me and to me known to be the same persons who executed the foregoing instrument and they acknowledged to me that the same is their free and voluntary act and deed.





























WITNESS MY HAND AND SEAL on the date and place first above written














































Doc No.

















Page No.

















Book No.

















Series of





























































































































































































































































































































































































































































Date Effective:

20 January 2020
Batch Notification Application Form

Form No.:





QWP-A/ANT/W-01 Annex 1
Revision No.: 11
Page 3 of 3

Sheet 3: DataBase
DATE BATCH NOTIFICATION NUMBER GENERIC NAME OTHERS BRAND NAME DOSAGE STRENGTH DOSAGE FORM ROUTE OF ADMINISTRATION BATCH NUMBER LOT NUMBER MANUFACTURING DATE EXPIRATION DATE REGISTRATION NUMBER CPR VALIDITY BATCH SIZE Theoretical Yield in Number of Units Actual Yield/Volumne of Importation in Number of Units (as indicated in the commercial invoice) Packaging Type Presentation or Pack Size Manufacturer's Name LTO Number LTO Validity Trader's Name LTO Number LTO Validity Importer's Name LTO Number LTO Validity Distributor's/ Wholesaler's Name LTO Number LTO Validity Repacker's Name LTO Number LTO Validity Others (Packed by; Packed For; Marketed By; Marketed For; Repacked for) LTO Number LTO Validity Company Name Printed Name Position/Designation Email Address Contact Number Date Assessed and Received by DATE OR NUMBER AMOUNT DATE VERSION
30 December 1899
List of Generic Names (please use drop down menu) (to be filled up if the generic name is not found in the drop down menu) 0 0 0 0

0 0
30 December 1899 0 0 0

0
30 December 1899 0
30 December 1899 0
30 December 1899 0
30 December 1899 0
30 December 1899 0
30 December 1899 0 0 0 0 0 30 December 1899
30 December 1899 0 50.00 30 December 1899 Revision No.: 11

The words contained in this file might help you see if this file matches what you are looking for:

...Sheet as form republic of the philippinesdepartment healthfood and drug administrationcivic drive filinvest corporate cityalabang city muntinlupa assessment slip dtn lab no date december company name product information list generic names please use drop down menu expiry batchlot number samples type request certificate evaluation amendment x batch notification others lot release vaccine lgu purchases purchase analysis requested visual examination aerobic plate count dissolution coliformecoli mpn ph yeast molds identification test presumptive salmonella tablet hardness staphylococcus aureus sterility heavy metals baterial endotoxin lal vitamins assaypotency single component multi assessed by payment details amount or effective nov qspcslpro annex revision page bn a n t i b o c d r u g p h f m e l y received director general php food administration civic alabang philippines attention common services laboratory sirmadam in accordance with administrative order we wish to apply notify fda o...

no reviews yet
Please Login to review.